IGC Pharma News - IGC

Company Name	Stock Ticker Symbol	Market	Type
IGC Pharma Inc	IGC	AMEX	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.0239	5.02%	0.50	17:31:46

Open Price	Low Price	High Price	Close Price	Prev Close
0.4857	0.47	0.508	0.49	0.4761

more quote information »

Recent News

Date	Time	Source	Heading
4/16/2024	07:00	BW	IGC-AD1’s Interim Phase 2 Data Show a Reduction in..
4/09/2024	09:00	BW	IGC Pharma Adds Advisor in Artificial Intelligence
3/26/2024	15:00	BW	IGC Pharma Announces $3 Million Unregistered Private..
3/20/2024	11:00	BW	IGC Pharma Announces Positive Interim Results for IGC-AD1 in..
3/20/2024	07:00	BW	IGC PHARMA Announces its Participation at the Benzinga..
3/12/2024	15:00	BW	IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins..
2/28/2024	13:00	BW	Promising Results: TGR-63 Enhances Memory in Alzheimer's..
2/23/2024	12:01	BW	IGC Pharma Announces Equity Analyst Coverage by Ascendiant..
2/16/2024	19:05	BW	IGC Pharma Reports Third Quarter Fiscal 2024 Results
2/14/2024	16:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/01/2024	09:20	BW	IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's..
1/31/2024	16:04	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
1/23/2024	09:20	BW	IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63..
1/17/2024	09:20	BW	IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing..
1/09/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
12/29/2023	16:54	EDGAR2	Form S-3 - Registration statement under Securities Act of..
12/19/2023	09:20	BW	Patent Granted to IGC Pharma for Groundbreaking Drug..
12/13/2023	09:30	BW	IGC Pharma Announces Participation in Biotech Showcase and..
12/06/2023	08:30	BW	IGC Pharma Announces Collaboration to Integrate AI into..
11/21/2023	08:30	BW	IGC Pharma Announces Master Agreement with Leading South..
11/13/2023	08:00	BW	IGC Pharma Reports Second Quarter Fiscal 2024 Results
11/09/2023	17:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/27/2023	17:21	EDGAR2	Form 8-K - Current report
10/27/2023	16:38	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
10/19/2023	15:30	BW	IGC Pharma Granted European Patent for Groundbreaking..
9/29/2023	17:23	EDGAR2	Form S-3 - Registration statement under Securities Act of..
8/21/2023	14:30	BW	IGC Announces Results of its 2023 Annual Stockholders..
8/21/2023	12:44	EDGAR2	Form 8-K - Current report
8/14/2023	08:30	BW	IGC Pharma Reports First Quarter Results; Company Continues..
8/10/2023	16:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/02/2023	08:30	BW	IGC Pharma Expands Phase 2 Trial of IGC-AD1 to Include the..
7/26/2023	17:26	EDGAR2	Form DEF 14A - Other definitive proxy statements
7/18/2023	05:22	BW	IGC Pharma, Inc. Presenting 6 Posters on the Positive Impact..
7/12/2023	08:44	BW	IGC Reports Financial Results for Fiscal Year Ended March..
7/07/2023	16:15	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
7/07/2023	11:41	EDGAR2	Form 8-K - Current report
7/07/2023	09:15	BW	IGC Pharma Secures $12 Million Line of Credit from O-Bank..
7/06/2023	07:46	BW	IGC Pharma Announces a $3 Million Private Placement of its..
6/30/2023	16:03	EDGAR2	Form NT 10-K - Notification of inability to timely file Form..
6/28/2023	21:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/28/2023	13:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/06/2023	09:20	BW	IGC Pharma Receives Notice of Allowance for Patent on..
6/05/2023	08:30	BW	IGC Pharma’s Advisor and Inventor of Drug Candidate TGR-63..